Cloxacillin Sodium
Dosage & Administration Guidelines
| Species | Route | Dose | Frequency | Duration & Clinical Notes |
|---|---|---|---|---|
| Dog | PO | 10-25 mg/kg | q8h | Duration: 5-7 days or as directed Notes: Administer on an empty stomach for optimal absorption. |
| Dog | IV/IM | 10-20 mg/kg | q8h | Duration: 5-7 days Notes: For severe infections. |
| Cat | PO | 10-20 mg/kg | q8h | Duration: 5-7 days Notes: Use with caution in cats due to potential GI upset. |
| Horse | IV/IM | 10-20 mg/kg | q6-8h | Duration: 5-7 days Notes: For systemic infections. |
| Cattle (lactating) | Intramammary | 200-500 mg per infected quarter | q12h for 2-3 milkings | Duration: 2-3 days Notes: Follow label instructions; milk withdrawal must be observed. |
| Cattle (dry cow) | Intramammary | 500 mg per quarter | Single infusion at drying off | Duration: Once Notes: For dry cow therapy. |
| Sheep/Goats | Intramammary | 200-500 mg per quarter | q12h for 2-3 milkings | Duration: 2-3 days Notes: Extra-label; milk withdrawal may be longer. |
| Rabbit | PO | 15-25 mg/kg | q12h | Duration: 5-7 days Notes: May cause GI disturbances; monitor for diarrhea. |
| Birds | PO/IM | 50-100 mg/kg | q8-12h | Duration: 5-7 days Notes: Limited data; use with caution. |
Clinical Indications & Species Uses
- Treatment of infections caused by penicillinase-producing staphylococci
- Prophylaxis in surgery (off-label)
- Treatment of pyoderma and skin infections caused by penicillinase-producing staphylococci
- Treatment of respiratory tract infections
- Treatment of urinary tract infections
- Treatment of wound infections
- Treatment of skin and soft tissue infections
- Treatment of respiratory tract infections
- Treatment of urinary tract infections
- Treatment of respiratory infections
- Treatment of skin and soft tissue infections
- Treatment of joint infections (septic arthritis) caused by susceptible staphylococci
- Treatment of mastitis caused by penicillinase-producing staphylococci (intramammary infusion)
- Treatment of respiratory infections (systemic use)
- Treatment of mastitis (intramammary)
- Treatment of skin infections
- Treatment of staphylococcal infections (e.g., abscesses, respiratory infections)
- Treatment of staphylococcal infections in small mammals (e.g., guinea pigs, rats) and reptiles (under expert guidance)
Pharmacology & Mechanism of Action
Drug Class: Antibiotic | Pharmacological Group: Penicillinase-resistant penicillin (beta-lactam)
Mechanism of Action: Cloxacillin is a semisynthetic penicillin that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs) and interfering with peptidoglycan cross-linking. It is resistant to staphylococcal penicillinase (beta-lactamase), making it effective against beta-lactamase-producing Staphylococcus species. It is bactericidal against susceptible organisms.
Pharmacodynamics: Cloxacillin exhibits time-dependent killing. Its efficacy is best correlated with the time that plasma concentrations exceed the minimum inhibitory concentration (MIC) of the organism. It is active primarily against Gram-positive bacteria, including penicillinase-producing staphylococci, and some streptococci. It is not effective against Gram-negative organisms due to poor penetration and beta-lactamase production.
⚡ Pharmacokinetics Summary
Available Formulations & Strengths
Contraindications & Clinical Warnings
- Hypersensitivity to penicillins or cephalosporins
- Use in animals with a history of allergic reactions to beta-lactam antibiotics
- Oral administration in ruminants (due to poor absorption and disruption of rumen flora)
- Systemic use in rabbits and guinea pigs (risk of enterotoxemia) - use with extreme caution
- Use with caution in animals with renal impairment (dosage adjustment may be necessary)
- In horses, use with caution as penicillins may cause diarrhea and Clostridioides difficile-associated colitis
- In cattle, observe milk withdrawal times and meat withdrawal times
- Intramammary infusion should be performed with strict aseptic technique
- Prolonged use may result in overgrowth of non-susceptible organisms (superinfection)
- Use in food animals must comply with regulatory guidelines (e.g., AMDUCA in the US)
Adverse Effects & Reactions
Common:
- Gastrointestinal upset (vomiting, diarrhea)
- Injection site pain or swelling
- Allergic reactions (rash, urticaria)
Serious / Severe:
- Anaphylaxis (rare but potentially fatal)
- Clostridioides difficile-associated diarrhea in horses
- Enterotoxemia in rabbits and guinea pigs
- Acute interstitial nephritis (rare)
Rare:
- Bone marrow suppression
- Hepatotoxicity
- Neurotoxicity (with high doses in renal failure)
Key Drug Interactions
| Interacting Drug / Class | Clinical Effect & Mechanism | Severity |
|---|---|---|
| Probenecid | Decreases renal tubular secretion of cloxacillin, increasing its plasma concentration and half-life. | Moderate |
| Bacteriostatic antibiotics (e.g., tetracyclines, macrolides) | May antagonize the bactericidal effect of cloxacillin; avoid concurrent use. | Moderate |
| Aminoglycosides | Synergistic effect against some Gram-positive bacteria; but do not mix in same syringe due to inactivation. | Mild |
| Methotrexate | Penicillins may reduce methotrexate clearance, increasing toxicity risk. | Moderate |
Overdose & Toxicity Management
Signs of Toxicity:
- Gastrointestinal signs (vomiting, diarrhea)
- Neurological signs (tremors, seizures) with very high doses
- Allergic reactions
Emergency Treatment Protocol: There is no specific antidote. Treatment is symptomatic and supportive. Induce emesis if recent oral ingestion and animal is stable. Administer activated charcoal to reduce absorption. Provide IV fluids for dehydration and electrolyte imbalances. Monitor for signs of anaphylaxis and treat with epinephrine and corticosteroids if needed. In severe cases, consider hemodialysis (though not commonly performed in veterinary patients).
Food Animal Withdrawal Times
Withdrawal times vary by formulation and country. For intramammary use in lactating cows, milk withdrawal is typically 3-4 days (72-96 hours) and meat withdrawal is 4-7 days. For dry cow therapy, meat withdrawal may be longer (e.g., 30 days). Always follow label instructions and local regulations.
Storage, Handling & Regulatory Information
Storage Temperature: Store at controlled room temperature 20-25°C (68-77°F), with excursions permitted between 15-30°C (59-86°F).
Light Sensitivity: Light-sensitive — protect from direct exposure.
Handling & Special Conditions: Protect from moisture. Reconstituted oral solutions should be refrigerated and used within 14 days. Intramammary syringes should be stored at room temperature and protected from freezing.
Dispensing Status: Prescription Required (Rx Only)
Approval Status: Approved for use in veterinary medicine; specific products are FDA-approved for intramammary infusion in cattle and oral/injectable formulations for dogs and cats (some are approved for horses).
Extra-Label (Off-Label) Use: In the US, extra-label use of cloxacillin in food animals is permitted under AMDUCA (Animal Medicinal Drug Use Clarification Act) only with a valid veterinary-client-patient relationship, and must follow established withdrawal times. Use in minor species may be extra-label. In the EU, similar regulations apply under Regulation (EU) 2019/6.
Clinical Pearls & Practice Notes
References & Literature
- 📚 Plumb's Veterinary Drug Handbook
- 📚 Papich Veterinary Pharmacology and Therapeutics
- 📚 Compendium of Veterinary Products (CVP)